240 Participants Needed

Acupressure for Sickle Cell Disease

Recruiting at 1 trial location
YW
Overseen ByYing Wang, MD, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial requires you to limit your current medications for pain control during the study visits, but it doesn't specify if you need to stop them completely. It's best to discuss your specific medications with the trial team.

What data supports the effectiveness of the treatment Acupressure for Sickle Cell Disease?

Research shows that non-drug approaches like deep tissue massage and acupressure can help relieve pain and improve the quality of life for people with sickle cell disease. Additionally, many patients with sickle cell disease use complementary therapies like massage to manage pain, indicating potential benefits.12345

Is acupressure safe for humans?

Research shows that acupressure is generally safe and well-tolerated, with no treatment-related adverse events reported in studies involving adults on hemodialysis and children undergoing medical procedures. Reflexology, a form of acupressure, is also considered safe with no side effects, although massage therapies can have rare risks like soft tissue trauma or spinal issues, especially with spinal manipulation.678910

How does acupressure treatment differ from other treatments for sickle cell disease?

Acupressure for sickle cell disease is unique because it is a non-drug approach that uses pressure on specific points of the body to relieve pain and improve quality of life, unlike traditional treatments that often rely on medications like opioids.134511

What is the purpose of this trial?

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

Eligibility Criteria

This trial is for adolescents and adults aged 14-80 with Sickle Cell Disease who have had chronic pain or a vaso-occlusive crisis in the past year. Participants must speak English, give consent, limit other pain treatments during the study, and commit to bi-daily acupressure sessions for 5 weeks.

Inclusion Criteria

I am between 14 and 80 years old.
I am willing to limit my pain medications during the study.
Fluent in English and capable of giving written informed consent
See 3 more

Exclusion Criteria

I have had a head injury that caused me to lose consciousness significantly.
I do not have severe psychiatric conditions like schizophrenia or major depression with suicidal thoughts.
I have used acupuncture or similar methods for pain management in the last 6 months.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive remote self-administered acupressure treatment every other day

5 weeks
Remote self-administration

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of pain, sleep quality, and quality of life

6 months
Remote follow-up visits

Treatment Details

Interventions

  • Acupressure 1
  • Acupressure 2
Trial Overview The study tests the effectiveness of acupressure analgesia on patients with Sickle Cell Disease. It involves two types of acupressure techniques to understand how they relieve pain and their underlying neurological mechanisms.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care + AcupressureExperimental Treatment1 Intervention
Participants will continue ongoing usual care and administer self-acupressure treatment.
Group II: Usual Care OnlyActive Control1 Intervention

Acupressure 1 is already approved in China, United States for the following indications:

πŸ‡¨πŸ‡³
Approved in China as Acupressure for:
  • Pain management
  • Osteoarthritis
πŸ‡ΊπŸ‡Έ
Approved in United States as Acupressure for:
  • Pain management
  • Sickle cell disease

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

University of California, Irvine

Collaborator

Trials
580
Recruited
4,943,000+

Findings from Research

A non-pharmacologic approach using deep tissue and deep pressure massage therapy, along with neuromuscular trigger point treatment and acupressure, significantly alleviates pain in patients with sickle cell disease (SCD).
This therapy not only helps reduce pain but also improves the overall quality of life for individuals suffering from SCD, which is crucial given the chronic pain and associated issues like depression and disability.
Non-pharmacologic management of sickle cell pain.Bodhise, PB., Dejoie, M., Brandon, Z., et al.[2011]
The GRACE study is evaluating the effectiveness of guided relaxation and acupuncture for managing chronic pain in sickle cell disease, involving 366 participants randomized into two intervention groups or usual care over a 24-week period.
The primary focus is on measuring changes in pain impact scores, along with secondary outcomes like opioid use and mental health factors, to determine the best treatment approach tailored to individual patient needs.
Hybrid effectiveness-implementation trial of guided relaxation and acupuncture for chronic sickle cell disease pain (GRACE): A protocol.Doorenbos, AZ., Schlaeger, JM., deMartelly, VA., et al.[2023]
A significant 92% of 227 surveyed African-American adults with sickle cell disease reported using complementary and alternative medicine (CAM) for pain management, with prayer, relaxation techniques, and massage being the most common methods.
The study highlights the need for further research to establish best practices that integrate conventional treatments with evidence-based CAM therapies for better pain control in sickle cell disease.
The use and effectiveness of complementary and alternative medicine for pain in sickle cell anemia.Majumdar, S., Thompson, W., Ahmad, N., et al.[2022]

References

Non-pharmacologic management of sickle cell pain. [2011]
Hybrid effectiveness-implementation trial of guided relaxation and acupuncture for chronic sickle cell disease pain (GRACE): A protocol. [2023]
The use and effectiveness of complementary and alternative medicine for pain in sickle cell anemia. [2022]
Developing an Implementation Blueprint for the NIH HEAL Initiative GRACE Trial: Perspectives on Acupuncture and Guided Relaxation for Chronic Sickle Cell Disease Pain. [2023]
A pilot study: the effect of healing touch on anxiety, stress, pain, pain medication usage, and physiological measures in hospitalized sickle cell disease adults experiencing a vaso-occlusive pain episode. [2013]
Massage for children undergoing hematopoietic cell transplantation: a qualitative report. [2023]
Adverse events of massage therapy in pain-related conditions: a systematic review. [2022]
Exploring approaches to patient safety: the case of spinal manipulation therapy. [2022]
The SIESTA Trial: A Randomized Study Investigating the Efficacy, Safety, and Tolerability of Acupressure versus Sham Therapy for Improving Sleep Quality in Patients with End-Stage Kidney Disease on Hemodialysis. [2020]
Reflexology--its place in modern healthcare. [2004]
Acupuncture for pediatric sickle cell pain management: A promising non-opioid therapy. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security